Table of Contents
MAPLE GROVE, Minn – Upsher-Smith Laboratories and the National Alliance of State Pharmacy Associations (NASPA) are pleased to announce that Jobby John, CEO and Founder of Nimbus Healthcare has been awarded a prestigious NASPA Excellence in Innovation Award. The award was presented by The Texas Pharmacy Association. The annual award recognizes pharmacists from across the nation for their outstanding contributions to the profession of pharmacy. It is coordinated by NASPA, sponsored by Upsher-Smith and presented by participating state pharmacy associations.
Jobby John
Jobby John, the driving force behind Nimbus Healthcare, stands at the forefront of innovation, harnessing the power of cutting-edge artificial intelligence (AI) algorithms with telemedicine to analyze individual patient data and deliver personalized, compounded prescriptions. By tailoring treatments to each patient’s unique needs, Nimbus Healthcare has not only improved patient outcomes but also significantly enhanced healthcare efficiency while reducing costs.
John was first inspired to become a pharmacist by his grandfather, who owned and operated an independent pharmacy in India. “My grandfather had such an impact on people in his community,” explained John. “I saw that growing up and wanted to be like him. Nimbus Healthcare has not only enhanced patient outcomes but also revolutionized healthcare efficiency by reducing costs and making top-tier healthcare more accessible. It is this commitment to innovative, patient-centered care that has earned Nimbus Healthcare the prestigious NASPA Excellence in Innovation Award.”
Nimbus Healthcare has created a trailblazing platform that delivers customized, efficient, and accessible medical solutions to patients across the United States. Central to its approach is the use of personalized medicine, where AI algorithms analyze individual patient data to understand unique health profiles. This data-driven insight enables the Company to create compounded prescriptions tailored specifically to each patient’s needs, ensuring a more effective and targeted approach to treatment. This AI technology not only assists in accurate diagnoses but also predicts health trends, allowing for proactive healthcare management. The telemedicine aspect of Nimbus ensures that this personalized care reaches patients irrespective of their location, especially beneficial for those in remote areas.
“Upsher-Smith is honored to partner with NASPA in recognizing pharmacists like Jobby John who continuously advance the profession of pharmacy and remain committed to improving patient care in their communities and beyond,” said Rich Fisher, President and COO, Upsher-Smith.
“We congratulate Jobby John, a leader in the field of pharmaceutical innovation, on being named a 2023 Excellence in Innovation Award recipient,” said Krystalyn Weaver, Executive Vice President and CEO, NASPA. “We are very grateful to our longstanding partner, Upsher-Smith, and the Texas Pharmacy Association for their continued support of this award.”
The Excellence in Innovation Award recognizes qualified pharmacists who have demonstrated significant innovation in their practice, method, or service directly or indirectly resulting in improved patient care and/or advancement of the profession of pharmacy. The award is presented by participating state pharmacy associations.
